Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPADES: Dovobet Gel in Poor-Adherence Plaque Psoriasis
jRCTs031180049Completed
- Sponsor
- LEO Pharma
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of betamethasone dipropionate in plaque psoriasis and psoriatic arthritis (PsA), sponsored by LEO Pharma. Primary endpoints: Drug preference at Weeks 4 and 12, Change in patient satisfaction (TSQM-9) from baseline to Weeks 4 and 12 and 1 more. Started Jan 2019; status: completed.
02
Drugs
betamethasone dipropionate
03
Conditions
plaque psoriasispsoriatic arthritis (PsA)
Beyond the preview
Go deeper on jRCTs031180049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180049.